Company Filing History:
1 out of 3,539 
1 out of 832,843 Years Active: 2013-2014
Title: The Innovative Contributions of Megan Peach
Introduction
Megan Peach is a notable inventor based in Ashburn, VA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the area of receptor tyrosine kinase inhibitors. With a total of 2 patents, her work focuses on advancing therapeutic methods for various medical conditions.
Latest Patents
Megan Peach's latest patents include compositions and methods for the inhibition of hepatocyte growth factor receptor c-Met signaling. The first patent details derivatives and analogs of inhibitors of receptor tyrosine kinase c-Met, along with pharmaceutical compositions containing these derivatives and analogs. It also outlines methods for making these derivatives and analogs, as well as their applications. The second patent similarly addresses compositions and methods for inhibiting c-Met signaling, specifically focusing on derivatives and analogs obtained through virtual screening. This patent also provides methods for creating these inhibitors and their potential uses.
Career Highlights
Throughout her career, Megan has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. Her research has contributed to the understanding and development of innovative therapeutic strategies.
Collaborations
Megan has collaborated with notable professionals in her field, including Donald P Bottaro and Marc Nicklaus. These partnerships have further enhanced her research and development efforts.
Conclusion
Megan Peach's innovative work in the field of pharmaceutical sciences exemplifies her commitment to advancing medical research. Her patents reflect her dedication to improving therapeutic options for patients.